NEUROSYSTEC CORPORATION Patent applications |
Patent application number | Title | Published |
20120208851 | FORMULATIONS - Colloidal suspensions comprising a therapeutic agent and squalene. Squalene binds to certain compounds, such as gacyclidine, much more tightly than other drug carriers, such as polylactic glycolic acid. Including squalene in the particulate phase sequesters the therapeutic agent and provides superior stability at room or body temperature. | 08-16-2012 |
20120208848 | GACYCLIDINE FORMULATIONS - Improved formulations of gacyclidine for direct administration to the inner or middle ear. | 08-16-2012 |
20110136870 | GACYCLIDINE FORMULATIONS - Improved formulations of gacyclidine for direct administration to the inner or middle ear. | 06-09-2011 |
20110071493 | Flow-Induced Delivery from a Drug Mass - Drug solutions (or other combinations of vehicle with entrained drug) are prepared by removing drug from one or more masses of a solid form of the drug. The solid form of the drug may be sparingly soluble or insoluble in water. Examples of devices for holding solid drug and facilitating delivery of such drug to targeted regions are also described. | 03-24-2011 |
20090209945 | VALVELESS IMPEDANCE PUMP DRUG DELIVERY SYSTEMS - A drug-delivery unit suitable for implantation into a patient body may include a valveless impedance pump. In some implementations the unit may include an actuator, control electronics and a battery, and may communicate with an external patient interface unit. The patient interface unit can be used to control operation of the implant and to download data from the implant. The patient interface unit can also be used to charge the implant and/or a separate charger can be used. In other implementations, a drug-delivery implant unit may lack internal electronics and instead rely on an externally-supplied magnetic field to actuate the pump. | 08-20-2009 |